181 related articles for article (PubMed ID: 37359561)
1. Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
Capolla S; Argenziano M; Bozzer S; D'Agaro T; Bittolo T; De Leo L; Not T; Busato D; Dal Bo M; Toffoli G; Cavalli R; Gattei V; Bomben R; Macor P
Front Immunol; 2023; 14():1200310. PubMed ID: 37359561
[TBL] [Abstract][Full Text] [Related]
2. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
Su YL; Swiderski P; Marcucci G; Kortylewski M
Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.
Argenziano M; Occhipinti S; Scomparin A; Angelini C; Novelli F; Soster M; Giovarelli M; Cavalli R
Drug Deliv Transl Res; 2022 Aug; 12(8):2007-2018. PubMed ID: 35672651
[TBL] [Abstract][Full Text] [Related]
5. microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus.
Bruni R; Marcantonio C; Pulsoni A; Tataseo P; De Angelis F; Spada E; Marcucci F; Panfilio S; Bianco P; Riminucci M; Villano U; Tosti M; Ciccaglione A; Mele A
BMC Infect Dis; 2014; 14 Suppl 5(Suppl 5):S6. PubMed ID: 25236768
[TBL] [Abstract][Full Text] [Related]
6. Functional evaluation of constructed pseudo-endogenous microRNA-targeted myocardial ultrasound nanobubble.
Ainiwan A; Wei Y; Dou J; Tang L; Mu Y; Guan L
Front Med (Lausanne); 2023; 10():1136304. PubMed ID: 37809333
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.
Plank MW; Maltby S; Tay HL; Stewart J; Eyers F; Hansbro PM; Foster PS
PLoS One; 2015; 10(12):e0144810. PubMed ID: 26693910
[TBL] [Abstract][Full Text] [Related]
9. Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140.
Beider K; Ribakovsky E; Abraham M; Wald H; Weiss L; Rosenberg E; Galun E; Avigdor A; Eizenberg O; Peled A; Nagler A
Clin Cancer Res; 2013 Jul; 19(13):3495-507. PubMed ID: 23637121
[TBL] [Abstract][Full Text] [Related]
10. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
11. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
[TBL] [Abstract][Full Text] [Related]
12. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
13. MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16.
Qian D; Chen K; Deng H; Rao H; Huang H; Liao Y; Sun X; Lu S; Yuan Z; Xie D; Cai Q
Clin Cancer Res; 2015 Nov; 21(21):4881-91. PubMed ID: 26100275
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy.
Ribeiro ML; Profitós-Pelejà N; Santos JC; Blecua P; Reyes-Garau D; Armengol M; Fernández-Serrano M; Miskin HP; Bosch F; Esteller M; Normant E; Roué G
Front Immunol; 2023; 14():1130052. PubMed ID: 37153563
[TBL] [Abstract][Full Text] [Related]
15. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.
Boss IW; Nadeau PE; Abbott JR; Yang Y; Mergia A; Renne R
J Virol; 2011 Oct; 85(19):9877-86. PubMed ID: 21813606
[TBL] [Abstract][Full Text] [Related]
16. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
[TBL] [Abstract][Full Text] [Related]
17. Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice.
Liu Y; Xie Q; Ma Y; Lin C; Li J; Hu B; Liu C; Zhao Y
Int J Pharm; 2022 Dec; 629():122352. PubMed ID: 36374798
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
19. Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo.
Maschmeyer P; Petkau G; Siracusa F; Zimmermann J; Zügel F; Kühl AA; Lehmann K; Schimmelpfennig S; Weber M; Haftmann C; Riedel R; Bardua M; Heinz GA; Tran CL; Hoyer BF; Hiepe F; Herzog S; Wittmann J; Rajewsky N; Melchers FG; Chang HD; Radbruch A; Mashreghi MF
J Autoimmun; 2018 May; 89():41-52. PubMed ID: 29183643
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
